EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Role of oxidative phosphorylation in the antidepressant effects of arketamine via the vagus nerve-dependent spleen-brain axis

Lijia Chang, Yan Wei, Youge Qu, Mingming Zhao, Xiangyu Zhou, Yang Long, Kenji Hashimoto

Neurobiology of Disease · 2024

DOI: 10.1016/j.nbd.2024.106573 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurobiology of Disease, 2024. Verfasst von Lijia Chang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan; Basic Medicine Research Innovation Cent…. Hauptthemen laut MEDLINE: Ketamine, Antidepressive Agents, Spleen, Vagus Nerve. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sichuan Province Science and Technology Support Program, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Arketamine, the (R)-enantiomer of ketamine, exhibits antidepressant-like effects in mice, though the precise molecular mechanisms remain elusive. It has been shown to reduce splenomegaly and depression-like behaviors in the chronic social defeat stress (CSDS) model of depression. This study investigated whether the spleen contributes to the antidepressant-like effects of arketamine in the CSDS model. We found that splenectomy significantly inhibited arketamine's antidepressant-like effects in CSDS-susceptible mice. RNA-sequencing analysis identified the oxidative phosphorylation (OXPHOS) pathway in the prefrontal cortex (PFC) as a key mediator of splenectomy's impact on arketamine's effects. Furthermore, oligomycin A, an inhibitor of the OXPHOS pathway, reversed the suppressive effects of splenectomy on arketamine's antidepressant-like effects. Specific genes within the OXPHOS pathways, such as COX11, UQCR11 and ATP5e, may contribute to these inhibitory effects. Notably, transforming growth factor (TGF)-β1, along with COX11, appears to modulate the suppressive effects of splenectomy and contribute to arketamine's antidepressant-like effects. Additionally, SRI-01138, an agonist of the TGF-β1 receptor, alleviated the inhibitory effects of splenectomy on arketamine's antidepressant-like effects. Subdiaphragmatic vagotomy also counteracted the inhibitory effects of splenectomy on arketamine's antidepressant-like effects in CSDS-susceptible mice. These findings suggest that the OXPHOS pathway and TGF-β1 in the PFC play significant roles in the antidepressant-like effects of arketamine, mediated through the spleen-brain axis via the vagus nerve.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineAntidepressive AgentsSpleenVagus NerveOxidative PhosphorylationMice, Inbred C57BLSplenectomyAnimalsMiceMaleDepressionPrefrontal CortexBrainStress, PsychologicalSocial Defeat

Stichwörter der Autor:innen

ArketamineOxidative phosphorylationSpleenSpleen-brain axisTransforming grow factor β1Vagus nerve

Substanzen

KetamineAntidepressive Agents

Autor:innen und Institutionen

  • Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan; Basic Medicine Research Innovation Center for Cardiometabolic Diseases, Ministry of Education, Southwest Medi…
  • Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan; Key Laboratory of Medical Electrophysiology, Ministry of Education & Medical Electrophysiological Key Laborat…
  • Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan.
  • Basic Medicine Research Innovation Center for Cardiometabolic Diseases, Ministry of Education, Southwest Medical University, Luzhou, 646000, China; Department of Thyroid and Vascular Surgery, The Affiliated Hospital, So…
  • Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, Sichuan 646000, China; Experimental Medicine Center, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China.
  • Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan. Electronic address: hashimoto@faculty.chiba-u.jp.

Förderung

  • Sichuan Province Science and Technology Support Program
  • Japan Society for the Promotion of Science

Zitieren

APA

Chang, L., Wei, Y., Qu, Y., Zhao, M., Zhou, X., Long, Y., & Hashimoto, K. (2024). Role of oxidative phosphorylation in the antidepressant effects of arketamine via the vagus nerve-dependent spleen-brain axis. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2024.106573

Vancouver

Chang L, Wei Y, Qu Y, Zhao M, Zhou X, Long Y, et al. Role of oxidative phosphorylation in the antidepressant effects of arketamine via the vagus nerve-dependent spleen-brain axis. Neurobiology of Disease. 2024. doi:10.1016/j.nbd.2024.106573

BibTeX
@article{Chang2024,
  author = {Chang, Lijia and Wei, Yan and Qu, Youge and Zhao, Mingming and Zhou, Xiangyu and Long, Yang and Hashimoto, Kenji},
  title = {Role of oxidative phosphorylation in the antidepressant effects of arketamine via the vagus nerve-dependent spleen-brain axis},
  journal = {Neurobiology of Disease},
  year = {2024},
  doi = {10.1016/j.nbd.2024.106573}
}
Kostenlos starten →